Clinical Trials
2 trialsNCT01898039 2025-10-02
Modified Vaccine for High Risk or Low Residual Melanoma Patients
Hadassah Medical Organization
Phase 1/2 Recruiting
NCT02054104 2022-01-26
Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated